|
HDAC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.26689999999597E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.279040E-03 |
| Normal-vs-Stage2 |
7.204200E-04 |
| Normal-vs-Stage3 |
1.003940E-04 |
| Normal-vs-Stage4 |
4.25860000000666E-05 |
| Stage1-vs-Stage2 |
2.028200E-01 |
| Stage1-vs-Stage3 |
1.322650E-01 |
| Stage1-vs-Stage4 |
5.851800E-02 |
| Stage2-vs-Stage3 |
8.928200E-01 |
| Stage2-vs-Stage4 |
8.141000E-01 |
| Stage3-vs-Stage4 |
6.597600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.376890E-04 |
| Normal-vs-AfricanAmerican |
3.755600E-01 |
| Normal-vs-Asian |
1.563960E-03 |
| Caucasian-vs-AfricanAmerican |
1.615040E-01 |
| Caucasian-vs-Asian |
8.267000E-01 |
| AfricanAmerican-vs-Asian |
1.450420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.788900E-04 |
| Normal-vs-Female |
1.990470E-04 |
| Male-vs-Female |
3.589400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.597200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.84500000000632E-05 |
| Normal-vs-Age(61-80Yrs) |
3.94350000000321E-05 |
| Normal-vs-Age(81-100Yrs) |
5.624300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.685700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.578000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.743000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.121800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.639000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.147600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.795600E-01 |
| Classical-VS-Follicular |
1.398370E-04 |
| Classical-VS-Other |
5.554600E-01 |
| Classical-VS-Normal |
1.074250E-02 |
| Tall-VS-Follicular |
8.792400E-02 |
| Tall-VS-Other |
7.400600E-01 |
| Tall-VS-Normal |
3.392400E-02 |
| Follicular-VS-Other |
5.356200E-01 |
| Follicular-VS-Normal |
1.05770000002892E-06 |
| Other-VS-Normal |
8.966200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89959999996603E-06 |
| Normal-vs-N1 |
4.384600E-04 |
| N0-vs-N1 |
9.994400E-01 |
|
|
